Hirakata H - Search Results

1

The impact of angiogenesis on the prognosis of advanced renal cell carcinomas.

Kawata N, Yagasaki H, Hirakata H, Nagane Y, Morita K, Sugimoto S, Igarashi T, Takimoto Y. Kawata N, et al. Among authors: hirakata h. Hinyokika Kiyo. 2004 Mar;50(3):157-63. Hinyokika Kiyo. 2004. PMID: 15148766 Free article.

2

[Enucleation of renal cell carcinoma in von Hippel-Lindau disease using a microwave tissue coagulator].

Igarashi T, Sakuma T, Yagasaki H, Igarashi T, Sugimoto S, Hirakata H, Kawata N, Takimoto Y. Igarashi T, et al. Among authors: hirakata h. Hinyokika Kiyo. 2004 Feb;50(2):91-3. Hinyokika Kiyo. 2004. PMID: 15101163 Free article. Japanese.

3

Long-term outcome from a study on the prevention of postoperative recurrence in patients with renal cell carcinoma: could PBL be a predictor of postoperative recurrence in patients postoperatively treated with IFN-gamma?

Kawata N, Ichinose T, Hachiya T, Hirakata H, Igarashi T, Nagane Y, Morita K, Takimoto Y. Kawata N, et al. Among authors: hirakata h. Hinyokika Kiyo. 2006 Aug;52(8):603-8. Hinyokika Kiyo. 2006. PMID: 16972621 Free article.

4

Strong significant correlation between MMP-9 and systemic symptoms in patients with localized renal cell carcinoma.

Kawata N, Nagane Y, Igarashi T, Hirakata H, Ichinose T, Hachiya T, Takimoto Y, Takahashi S. Kawata N, et al. Among authors: hirakata h. Urology. 2006 Sep;68(3):523-7. doi: 10.1016/j.urology.2006.03.063. Epub 2006 Sep 18. Urology. 2006. PMID: 16979746

5

Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.

Kawata N, Nagane Y, Hirakata H, Ichinose T, Okada Y, Yamaguchi K, Takahashi S. Kawata N, et al. Among authors: hirakata h. Urology. 2007 Jun;69(6):1049-53. doi: 10.1016/j.urology.2007.02.044. Urology. 2007. PMID: 17572184

6

How do symptoms have an impact on the prognosis of renal cell carcinoma?

Kawata N, Nagane Y, Yamaguchi K, Ichinose T, Hirakata H, Takahashi S. Kawata N, et al. Among authors: hirakata h. Int J Urol. 2008 Apr;15(4):299-303. doi: 10.1111/j.1442-2042.2008.01990.x. Int J Urol. 2008. PMID: 18380815

7

Metastasectomy for renal cell carcinoma as a strategy to obtain complete remission.

Yamaguchi K, Kawata N, Nagane Y, Igarashi H, Sugimoto S, Hirakata H, Takahashi S, Higaki T. Yamaguchi K, et al. Among authors: hirakata h. Int J Clin Oncol. 2010 Oct;15(5):519-22. doi: 10.1007/s10147-010-0077-2. Epub 2010 May 7. Int J Clin Oncol. 2010. PMID: 20449622

8

Cytoreductive surgery with liver-involved renal cell carcinoma.

Kawata N, Hirakata H, Yuge H, Kodama M, Sugimoto S, Yagasaki H, Mochida J, Fujimura K, Takimoto Y. Kawata N, et al. Among authors: hirakata h. Int J Urol. 2000 Oct;7(10):382-5. doi: 10.1046/j.1442-2042.2000.00209.x. Int J Urol. 2000. PMID: 11144507 Free article.

9

Histopathologic analysis of angiogenic factors in localized renal cell carcinoma: the influence of neoadjuvant treatment.

Kawata N, Yagasaki H, Yuge H, Nakanoya Y, Fujimura K, Sugimoto S, Hirakata H, Takimoto Y. Kawata N, et al. Among authors: hirakata h. Int J Urol. 2001 Jun;8(6):275-81. doi: 10.1046/j.1442-2042.2001.00299.x. Int J Urol. 2001. PMID: 11389742 Free article.

10

[Clinical trial of inhalant recombinant interferon-gamma in patients with pulmonary metastasis from renal tumor (preliminary report)].

Kawata N, Takimoto Y, Hirakata H, Fuse T, Hirano D, Yamanaka Y. Kawata N, et al. Among authors: hirakata h. Hinyokika Kiyo. 1994 Sep;40(9):773-6. Hinyokika Kiyo. 1994. PMID: 7801837 Free article. Clinical Trial. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters